Abstract

Establishing a Rationale for Compounding Hormone Replacement Therapy

Author(s): Biundo Bruce

Issue: May/Jun 2018 - Volume 22, Number 3

Page(s): 190-195

Download in electronic PDF format for $75

Abstract

Why compound bioidentical hormones? Are there no similar commercial products? What is unique about the options compounding pharmacists offer compared with what is out in the marketplace? These are questions that physicians and other practitioners are asking, and it is very important that we have intelligent, well-thought answers when we respond. Times have changed, and the challenges we face today in marketing our compounded therapies are not the same as those of twenty years ago. Premarin is no longer at the top of the heap, and there are topical, commercial products that contain bioidentical estradiol, and capsules that contain the same progesterone that we use. Our compounding advantage comes from our abilities to prepare unique patient-specific products, and, very importantly, from our growing understanding of hormone receptors; we now know there are two main estrogen receptors, 1) estrogen receptor alpha and 2) estrogen receptor beta, and the growing knowledge base associated with the discovery of estrogen receptor beta is quite significant.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2018 Pg. 190-195	Establishing a Rationale for Compounding Hormone Replacement Therapy Author(s): Biundo Bruce
Jan/Feb 2024 Pg. 22-27	Establishing a Rationale for Compounding Hormone Replacement Therapy Author(s): Biundo Bruce
Sep/Oct 2016 Pg. 359-364	Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Author(s): Deleruyelle Laura J
Nov/Dec 2016 Pg. 447-454	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Author(s): Deleruyelle Laura J
Jul/Aug 2003 Pg. 250-256	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Author(s): Gillson George R, Zava David T
Jul/Aug 2011 Pg. 290-300	Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Author(s): Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Jan/Feb 2001 Pg. 52-54	Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Author(s): Ford Gina, Garcia Lea
Jan/Feb 2017 Pg. 6-16	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 Author(s): Deleruyelle Laura J
Jul/Aug 2004 Pg. 313-319	Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Author(s): Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J
Mar/Apr 2002 Pg. 142-146	Bioidentical Hormone Replacement Therapy, Part 3, A Review of Author(s): Wepfer Scott T
Jan/Feb 2002 Pg. 50-54	Bioidentical Hormone Replacement Therapy, Part 2, A Review of Author(s): Wepfer Scott T
Jan/Feb 2015 Pg. 6-12	Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2010 Pg. 165-170	Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study Author(s): Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Sep/Oct 2003 Pg. 330-338	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 Author(s): Gillson George R, Zava David T
Jan/Feb 2014 Pg. 70-77	The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study Author(s): Ruiz Andres D, Daniels Kelly R
Sep/Oct 2009 Pg. 392-399	Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing Author(s): Kells John, Dollbaum Charles M
Nov/Dec 2003 Pg. 490-494	Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations Author(s): Branvold Andrea, Barner Jamie C
Jul/Aug 2005 Pg. 266	Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy Author(s): White Irene Q
Mar/Apr 2012 Pg. 110-114	Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Author(s): Griffee Chris, Delano Amy